Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Atrion Corporation (ATRI) stocks in Canada

Learn how to easily invest in Atrion Corporation stocks.

Atrion Corporation is a medical instruments & supplies business based in the US. Atrion Corporation stocks (ATRI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $594.24 – a decrease of 4.29% over the previous week. Atrion Corporation employs 636 staff and has a trailing 12-month revenue of around $157 million.

How to buy shares in Atrion Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ATRI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Atrion Corporation stock price (NASDAQ:ATRI)

Use our graph to track the performance of ATRI stocks over time.

Atrion Corporation shares at a glance

Information last updated 2022-01-23.
Latest market close$608.73
52-week range$576.88 - $803.41
50-day moving average $706.80
200-day moving average $670.18
Wall St. target price$300.00
PE ratio 34.8723
Dividend yield $7.2 (1.26%)
Earnings per share (TTM) $17.70

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Atrion Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Atrion Corporation price performance over time

Historical closes compared with the close of $608.73 from 2022-01-26

1 week (2022-01-16) N/A
1 month (2021-12-23) -7.69%
3 months (2021-10-26) -14.68%
6 months (2021-07-27) 0.43%
1 year (2021-01-27) -8.71%
2 years (2020-01-27) -15.57%
3 years (2019-01-25) 780
5 years (2017-01-27) 20.46%

Is Atrion Corporation under- or over-valued?

Valuing Atrion Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Atrion Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Atrion Corporation's P/E ratio

Atrion Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, Atrion Corporation shares trade at around 35x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Atrion Corporation's EBITDA

Atrion Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $47.2 million.

The EBITDA is a measure of a Atrion Corporation's overall financial performance and is widely used to measure a its profitability.

Atrion Corporation financials

Revenue TTM $157 million
Operating margin TTM 22%
Gross profit TTM $66.2 million
Return on assets TTM 8.11%
Return on equity TTM 13.53%
Profit margin 20.58%
Book value $132.86
Market capitalisation $1.1 billion

TTM: trailing 12 months

Atrion Corporation share dividends

41%

Dividend payout ratio: 40.52% of net profits

Recently Atrion Corporation has paid out, on average, around 40.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Atrion Corporation shareholders could enjoy a 1.26% return on their shares, in the form of dividend payments. In Atrion Corporation's case, that would currently equate to about $7.2 per share.

While Atrion Corporation's payout ratio might seem fairly standard, it's worth remembering that Atrion Corporation may be investing much of the rest of its net profits in future growth.

Atrion Corporation's most recent dividend payout was on 14 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 November 2021 (the "ex-dividend date").

Have Atrion Corporation's shares ever split?

Atrion Corporation's shares were split on a 3:2 basis on 2 December 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Atrion Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Atrion Corporation shares which in turn could have impacted Atrion Corporation's share price.

Atrion Corporation share price volatility

Over the last 12 months, Atrion Corporation's shares have ranged in value from as little as $576.8842 up to $803.4142. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atrion Corporation's is 0.0791. This would suggest that Atrion Corporation's shares are less volatile than average (for this exchange).

Atrion Corporation overview

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, mixes critical drugs, controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site